International Clinical Trial: A First-in-human Phase-1 PET Imaging Study of [64Cu]IS1051 in Participants with Suspected Infection

Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001031358) titled 'A First-in-human Phase-1 PET Imaging Study of [64Cu]IS1051 in Participants with Suspected Infection' on Aug. 21.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Type of endpoint: Safety/efficacy

Primary Sponsor: iSeek Biopharma AU Pty Ltd

Condition: Infection Infection Infection - Studies of infection and infectious agents Infection - Other infectious diseases

Intervention: [64Cu]IS1051is a novel, radioactive small-molecule ligand that binds specifically to LFA-1, a leukocyte surface integrin involved in immune-cell adhesion and migration. Radiolabelling with...